Role of mast cells, stem cell factor and protease-activated receptor-2 in tubulointerstitial lesions in IgA nephropathy

By Liu Hong   Liu Fuyou   Peng Youming   Liu Yinghong   Li Lingyan   Tu Xiwen   Cheng Meichu   Xu Xiangqing   Chen Xing   Ling Guanghui   Sun Lin  

Inflammation Research, Vol. 59, Iss. 7, 2010-07 ,pp. : 551-559

Springer Publishing Company

Access to resources Recommend Favorite

Anti-CD4 monoclonal antibody/tumour necrosis factor α inhibitors: Cytokine release syndromes, allergy, CD4+ T-cell lymphopenia and maculopapular rash: 8 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1199, 2008-01 ,pp. : 6-7

Adis International

Access to resources Recommend Favorite

Isolated rat stomach ECL cells generate prostaglandin E 2 in response to interleukin-1 , tumor necrosis factor- and bradykinin

By Lindstrom E.   Lerner U.H.   Hakanson R.  

European Journal of Pharmacology, Vol. 416, Iss. 3, 2001-03 ,pp. : 255-263

Elsevier

Access to resources Recommend Favorite

Anti-tumour necrosis factor therapy in seronegative spondyloarthritis

By Swales Catherine   Bowness Paul  

Clinical Medicine, Vol. 5, Iss. 3, 2005-05 ,pp. : 219-222

Royal College Of Physicians

Access to resources Recommend Favorite

Induction of human airway hyperresponsiveness by tumour necrosis factor-

By Anticevich S.Z.   Hughes J.M.   Black J.L.   Armour C.L.  

European Journal of Pharmacology, Vol. 284, Iss. 1, 1995-09 ,pp. : 221-225

Elsevier

Access to resources Recommend Favorite